DAIC
MARCH 27, 2025
In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. 2023 Oct, 82 (16) 15981610.
Dr. Paddy Barrett
DECEMBER 13, 2024
Excess weight, as measured by BMI, is typically considered a measure of excess body fat. When someone is classified as being of ‘normal’ weight, that typically means they have a BMI of less than 25. The relationship between excess weight, a high BMI and the risk of severe insulin resistance and diabetes is clear 4.
Frontiers in Cardiovascular Medicine
JANUARY 15, 2024
Female patients showed a lower prevalence rate of pre-existing coronary artery disease (48% vs. 75%, p < 0.001) and cardiomyopathy (17% vs. 34%, p = 0.01) compared with the male patients, while the mean age and prevalence rate of other cardiovascular risk factors were balanced.
Stroke Journal
FEBRUARY 1, 2024
Body mass index (BMI) is a widely available marker of nutrition status, however studies on BMI and post-ICH outcomes are limited and have conflicting results. Patients were divided into underweight, normal weight, overweight, and obese according to World Health Organization BMI criteria. 7.34) and lobar (OR 3.15, 95% CI 1.67-5.94)
Physiologically Speaking
JANUARY 5, 2024
Importantly, all of the participants had recently undergone percutaneous coronary intervention (PCI) — a surgical procedure in which a stent is placed in a coronary artery to open up a blockage. All of the participants had stable coronary artery disease and were on lipid-lowering therapies during the study.
DAIC
MAY 10, 2024
“Fat-enlarged axillary lymph nodes visualized on screening mammography may increase the ability to identify women who would benefit from CVD risk reduction strategies and more intensive risk assessment with coronary artery CT.” Rubino et al.
Dr. Paddy Barrett
OCTOBER 31, 2023
An elevated Lp(a) is a common genetic factor that is independently and causally related to premature coronary artery disease. The occurrence of disease in this instance is probabilistic, not deterministic. An elevated Lp(a) does increase the risk of early cardiovascular disease, but that risk is not set in stone.
Expert insights. Personalized for you.
52 
Let's personalize your content